Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)

Not Applicable

Terminated

Conditions: Pain
Chemotherapy-induced Peripheral Neuropathy
Neuropathy

First Posted Date: 2024-03-21

Last Posted Date: 2024-12-30

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 10

Registration Number: NCT06324344

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children

Recruiting

Conditions: Coloboma
Anophthalmia
Microphthalmia

First Posted Date: 2024-03-05

Last Posted Date: 2025-03-28

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 3000

Registration Number: NCT06293560

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Telehealth Behavioral Activation for Teens

Not Applicable

Recruiting

Conditions: Depression
Suicide and Self-harm
Depression Severe
Depression in Adolescence
Depression Mild
Depression Moderate

First Posted Date: 2024-02-23

Last Posted Date: 2024-06-21

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 250

Registration Number: NCT06273995

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders

Recruiting

Conditions: RAI1 Gene 17P11.2 Deletion+Duplication

First Posted Date: 2024-02-23

Last Posted Date: 2025-05-25

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 90

Registration Number: NCT06274164

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Phase 1

Not yet recruiting

Conditions: Breast Tumor
Mammary Neoplasm
Mammary Neoplasms, Human
Breast Cancer
Malignant Neoplasm of Breast
Neoplasm, Breast
Mammary Cancer
Tumor, Breast

First Posted Date: 2024-02-09

Last Posted Date: 2025-07-08

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 27

Registration Number: NCT06251544

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Phase 1

Not yet recruiting

Conditions: Yolk Sac Tumor
Wilms Tumor
Embryonal Sarcoma of Liver
Rhabdomyosarcoma
Hepatoblastoma
Liposarcoma
Hepatocellular Carcinoma
Malignant Rhabdoid Tumor

First Posted Date: 2024-01-10

Last Posted Date: 2025-06-06

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 21

Registration Number: NCT06198296

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

SCREENS: Sleep, Circadian Rhythms, and Electronics in the EveNing Study

Not Applicable

Recruiting

Conditions: Executive Function
Circadian Rhythm
Sleep
Emotion Regulation

First Posted Date: 2024-01-05

Last Posted Date: 2025-05-09

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 220

Registration Number: NCT06192745

Locations: 🇺🇸
Children's Nutrition Research Center, Houston, Texas, United States

Emergency Room HPV Self-Sampling Study (ACT NOW)

Not Applicable

Completed

Conditions: Cervical Cancer Screening

First Posted Date: 2023-12-21

Last Posted Date: 2025-01-15

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 100

Registration Number: NCT06178549

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

Phase 1

Not yet recruiting

Conditions: CD30-Positive Diffuse Large B-Cell Lymphoma
Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type
Anaplastic Large Cell Lymphoma, ALK-Positive
Peripheral T-cell Lymphoma
Non-Hodgkin Lymphoma
Anaplastic Large Cell Lymphoma, ALK-negative
Hodgkin Lymphoma

Interventions: Biological: C7R.CD30.CAR-EBVST cells

First Posted Date: 2023-12-20

Last Posted Date: 2025-07-04

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 90

Registration Number: NCT06176690

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Traction vs. No Traction in Colonic ESD

Not Applicable

Recruiting

Conditions: Gastrointestinal Neoplasm

First Posted Date: 2023-12-07

Last Posted Date: 2025-01-15

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 150

Registration Number: NCT06159634

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Baylor St. Lukes Medical Center (BSLMC), Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy